#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	10006	16S	1529	1529	100.0	16S.l15.c4.ctg.1	1966	859.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1368	1368	C	1102	C	622	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	17682	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3868	749.6	0	.	n	.	0	T695C	SNP	695	695	T	1110	1110	C	1087	C,A,G	591,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	17682	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3868	749.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1752	1752	A	866	A	486	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	17682	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3868	749.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2386	2386	C	806	C,A	456,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	17682	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3868	749.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2460	2460	A	847	A,G	475,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	17682	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3868	749.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	3012	3012	C	979	C	579	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	598	folP	852	852	100.0	folP.l15.c4.ctg.1	1397	75.4	1	SNP	p	R228S	1	.	.	682	684	AGC	926	928	AGC	109;111;114	A;G;C	62;63;65	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1802	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3282	91.9	1	SNP	p	S91F	1	.	.	271	273	TTC	589	591	TTC	146;146;146	T;T;C	79;81;79	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1802	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3282	91.9	1	SNP	p	G95N	0	.	.	283	285	GGC	601	603	GGC	152;156;156	G;G;C	84;85;84	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1802	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3282	91.9	1	SNP	p	D95G	1	.	.	283	285	GGC	601	603	GGC	152;156;156	G;G;C	84;85;84	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	442	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1285	60.4	0	.	p	.	0	A39T	NONSYN	115	117	GCC	451	453	ACC	120;121;121	A;C;C	67;66;67	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	442	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1285	60.4	0	.	p	.	0	R44H	NONSYN	130	132	CGC	466	468	CAC	121;121;121	C;A;C	65;70;70	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	442	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1285	60.4	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	649	651	CAC	103;98;99	C;A,G;C	59;53,1;55	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	442	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1285	60.4	1	SNP	p	G45D	0	.	.	133	135	GGC	469	471	GGC	121;121;121	G;G;C	68;69;68	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	352	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c4.ctg.1	778	79.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1660	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2985	95.5	1	SNP	p	D86N	0	.	.	256	258	GAC	456	458	GAC	128;128;130	G;A;C	75;74;77	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1660	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2985	95.5	1	SNP	p	S87W	0	.	.	259	261	AGT	459	461	AGT	124;129;131	A;G;T,G	73;75;73,1	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1660	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2985	95.5	1	SNP	p	S87R	0	.	.	259	261	AGT	459	461	AGT	124;129;131	A;G;T,G	73;75;73,1	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1660	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2985	95.5	1	SNP	p	S87I	0	.	.	259	261	AGT	459	461	AGT	124;129;131	A;G;T,G	73;75;73,1	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1660	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2985	95.5	1	SNP	p	S88P	0	.	.	262	264	TCC	462	464	TCC	131;131;127	T;C;C	78;78;77	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1320	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2744	83.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1660	1662	GGC	97;97;97	G;G;C	58;55;50	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	1714	penA	1749	1749	100.0	penA.l15.c4.ctg.1	1983	140.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1020	1022	GCA	206;206;208	G;C;A	117;120;120	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1714	penA	1749	1749	100.0	penA.l15.c4.ctg.1	1983	140.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1023	1025	ATC	210;210;210	A;T;C	119;118;118	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1714	penA	1749	1749	100.0	penA.l15.c4.ctg.1	1983	140.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1035	1037	GTG	211;212;213	G;T;G	120;118;119	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1714	penA	1749	1749	100.0	penA.l15.c4.ctg.1	1983	140.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1035	1037	GTG	211;212;213	G;T;G	120;118;119	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1714	penA	1749	1749	100.0	penA.l15.c4.ctg.1	1983	140.7	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1539	1541	ACC	96;96;93	A;C;C	56;60;59	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1714	penA	1749	1749	100.0	penA.l15.c4.ctg.1	1983	140.7	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1593	1595	GCG	80;79;79	G;C;G	46;45;48	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1714	penA	1749	1749	100.0	penA.l15.c4.ctg.1	1983	140.7	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1593	1595	GCG	80;79;79	G;C;G	46;45;48	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1714	penA	1749	1749	100.0	penA.l15.c4.ctg.1	1983	140.7	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1716	1718	GGC	84;84;84	G;G;C	52;53;51	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1714	penA	1749	1749	100.0	penA.l15.c4.ctg.1	1983	140.7	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1725	1727	GGC	74;71;69	G;G;C	48;45;43	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1714	penA	1749	1749	100.0	penA.l15.c4.ctg.1	1983	140.7	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1743	1745	CCG	81;77;75	C;C;G	36;41;37	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	3046	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	2709	172.9	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1415	1417	CTG	103;103;104	C;T;G	53;58;59	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	870	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1739	79.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	537	537	C	50	C	28	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	78	porB1a	984	205	94.63	porB1a.l15.c4.ctg.2	210	11.1	0	.	p	.	0	S271T	NONSYN	811	813	TCG	102	104	ACT	12;12;12	A;C;T	6;6;6	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	78	porB1a	984	205	94.63	porB1a.l15.c4.ctg.2	210	11.1	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	108	110	GAT	12;12;12	G;A;T	6;6;6	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	78	porB1a	984	205	94.63	porB1a.l15.c4.ctg.2	210	11.1	0	.	p	.	0	D276N	NONSYN	826	828	GAT	117	119	AAC	12;12;12	A;A;C	6;6;6	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	78	porB1a	984	205	94.63	porB1a.l15.c4.ctg.2	210	11.1	0	.	p	.	0	N277H	NONSYN	829	831	AAC	120	122	CAC	12;12;12	C;A;C	6;6;6	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	898	porB1b	1047	1047	96.2	porB1b.l15.c17.ctg.1	1464	103.4	0	.	p	.	0	D41K	NONSYN	121	123	GAC	350	352	AAA	136;138;131	A;A;A	79;78;76	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	898	porB1b	1047	1047	96.2	porB1b.l15.c17.ctg.1	1464	103.4	0	.	p	.	0	A109V	NONSYN	325	327	GCC	554	556	GTC	65;65;65	G,T;T;C	35,1;34;36	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	898	porB1b	1047	1047	96.2	porB1b.l15.c17.ctg.1	1464	103.4	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	620	622	TAT	67;67;67	T;A;T	41;41;42	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	898	porB1b	1047	1047	96.2	porB1b.l15.c17.ctg.1	1464	103.4	0	.	p	.	0	N134E	NONSYN	400	402	AAT	629	631	GAG	60;58;58	G;A;G	36;37;36	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	898	porB1b	1047	1047	96.2	porB1b.l15.c17.ctg.1	1464	103.4	0	.	p	.	0	V135L	NONSYN	403	405	GTG	632	634	CTT	60;60;60	C;T;T	38;38;40	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	898	porB1b	1047	1047	96.2	porB1b.l15.c17.ctg.1	1464	103.4	0	.	p	.	0	G140K	NONSYN	418	420	GGA	647	649	AAA	62;64;64	A;A;A	37;39;39	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	898	porB1b	1047	1047	96.2	porB1b.l15.c17.ctg.1	1464	103.4	0	.	p	.	0	K143G	NONSYN	427	429	AAA	656	658	GGA	67;67;67	G;G;A	40;40;36	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	898	porB1b	1047	1047	96.2	porB1b.l15.c17.ctg.1	1464	103.4	0	.	p	.	0	V151A	NONSYN	451	453	GTA	680	682	GCA	88;89;89	G;C;A	49;51;50	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	898	porB1b	1047	1047	96.2	porB1b.l15.c17.ctg.1	1464	103.4	0	.	p	.	0	D171G	NONSYN	511	513	GAC	740	742	GGT	124;124;122	G,A;G;T	75,1;76;69	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	898	porB1b	1047	1047	96.2	porB1b.l15.c17.ctg.1	1464	103.4	0	.	p	.	0	Q187R	NONSYN	559	561	CAA	788	790	CGA	116;116;116	C;G;A	70;70;70	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	898	porB1b	1047	1047	96.2	porB1b.l15.c17.ctg.1	1464	103.4	0	.	p	.	0	Y211_E212insL	INS	631	631	T	860	860	T	110	T	70	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	898	porB1b	1047	1047	96.2	porB1b.l15.c17.ctg.1	1464	103.4	0	.	p	.	0	E212D	NONSYN	634	636	GAA	866	868	GAT	106;106;101	G;A;T	66;64;62	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	898	porB1b	1047	1047	96.2	porB1b.l15.c17.ctg.1	1464	103.4	0	.	p	.	0	H213D	NONSYN	637	639	CAT	869	871	GAT	101;99;99	G;A;T	62;63;62	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	898	porB1b	1047	1047	96.2	porB1b.l15.c17.ctg.1	1464	103.4	0	.	p	.	0	Q214fs	FSHIFT	640	640	C	872	872	C	99	C	62	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	4462	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4753	155.5	1	SNP	p	H553N	1	.	.	1657	1659	AAT	1821	1823	AAT	178;181;183	A;A;T	102;101;106	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	346	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1112	56.9	1	SNP	p	V57M	1	.	.	169	171	ATG	530	532	ATG	119;115;115	A;T,A;G	69;69,1;70	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
